Scientists test 'Allergy Shot' for diabetes to stop Body's Self-Attack
NCT ID NCT04590872
Summary
This early-stage study is testing the safety of a personalized vaccine for adults recently diagnosed with type 1 diabetes. The vaccine is made from a patient's own immune cells and a piece of a pancreas protein. The goal is to teach the immune system to stop attacking the body's insulin-producing cells, potentially helping them recover. This small pilot trial will enroll 6 participants to check for side effects and see if making the vaccine is practical.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Conditions
Explore the condition pages connected to this study.